Erythropoietin and intravenous iron in PBM

Transfusion and Apheresis Science

Volumn 50, Issue 1, 2014, Pages 16-19

  Ralley, Fiona E ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; ANTIANEMIC AGENT;

ANEMIA; BLOOD TRANSFUSION; ELECTIVE SURGERY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HIP ARTHROPLASTY; HUMAN; IRON DEFICIENCY ANEMIA; IRON STORAGE; PATIENT BLOOD MANAGEMENT; PATIENT CARE; PROSPECTIVE STUDY; REVIEW; SUPPLEMENTATION; THROMBOCYTOSIS; THROMBOSIS; TOTAL HIP PROSTHESIS; BLOOD STORAGE; COMPLICATION; CYTOLOGY; DIET SUPPLEMENTATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PREOPERATIVE PERIOD; PROCEDURES;

ADMINISTRATION, INTRAVENOUS; ANEMIA; BLOOD PRESERVATION; BLOOD TRANSFUSION; DIETARY SUPPLEMENTS; ERYTHROCYTES; ERYTHROPOIETIN; HEMATINICS; HUMANS; IRON; PREOPERATIVE PERIOD;

EID: 84897027759     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.12.007     Document Type: Review

References (19)

1. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81:2-10.
2. Carson J., Duffa, Poses R.M., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996, 348:1055-1060.
3. Musallam K.M., Tamim H.M., Richards T., et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011, 378:1396-1407.
4. Khanna M.P., Hebert P.C., Fergusson D.A. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfus Med Rev 2003, 17:110-119.
5. Cuenca J., Garcia-Erce J.A., Martinez F., Pérez-Serrano L., Herrera A., Muñoz M. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006, 46:1112-1119.
6. Silverstein S.B., Rodgers G.M. Parenteral iron therapy options. Am J Hematol 2004, 76:74-78.
7. Auerbach M., Chaudhry M., Goldman H., Ballard H. Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial. J Lab Clin Med 1998, 131:257-260.
8. Asero R. Multiple drug allergy syndrome: a distinct clinical entity. Curr Allergy Rep 2001, 1:18-22.
9. Coyne D.W., Adkinson N.F., Nissenson A.R., et al. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensative and dextran-tolerant patients. Kidney Int 2003, 63:217-224.
10. Chandler G., Harchowal J., Macdougal J.C. Intravenous iron sucrose establishing a safe dose. Am J Kidney Dis 2001, 38:988-991.
11. Folkert V.W., Michael D.O., Agarval R., et al. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (≥250mg) administration. Am J Kidney Dis 2003, 41:651-657.
12. FerahemeTM (ferumoxytol) injection prescribing information 2010, AMAG Pharmaceuticals Inc, Lexington, MA.
13. Spinowitz B.S., Kausz A.T., Baptista J., et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol 2008, 19:1599-1605.
14. Pfeffer M.A., Burdmann E.A., Chen C.Y., et al. A trial of darbepoetin alpha in type 2 diabetes and chronic kidney disease. N Engl J Med 2009, 361:2019-2032.
15. de Andrade J.R., Frei D., Guilfoyle M. Integrated analysis of thrombotic/vascular event occurrence in epoetin alfatreated patients undergoing major, elective orthopedic surgery. Orthopedics 1999, 22:s113-s118.
16. Na H.S., Shin S.Y., Hwang J.Y., et al. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011, 51:118-124.
17. Munoz M., Campos A., Garcia-Erce J.A. Intravenous iron in colo-rectal cancer surgery. Semin Hematol 2006, 43:S36-S38.
18. Feagan B.G., Wong C.J., Kirkley A., et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 2000, 133:845-854.
19. Gonzalez-Porras J.R., Colado E., Conde M.P., et al. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty. Transfus Med 2009, 19:35-42.